Share Email Print
cover

Proceedings Paper

Optimization model for UV-Riboflavin corneal cross-linking
Author(s): S. Schumacher; J. Wernli; S. Scherrer; M. Bueehler; T. Seiler; M. Mrochen
Format Member Price Non-Member Price
PDF $14.40 $18.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

Nowadays UV-cross-linking is an established method for the treatment of keraectasia. Currently a standardized protocol is used for the cross-linking treatment. We will now present a theoretical model which predicts the number of induced crosslinks in the corneal tissue, in dependence of the Riboflavin concentration, the radiation intensity, the pre-treatment time and the treatment time. The model is developed by merging the difussion equation, the equation for the light distribution in dependence on the absorbers in the tissue and a rate equation for the polymerization process. A higher concentration of Riboflavin solution as well as a higher irradiation intensity will increase the number of induced crosslinks. However, performed stress-strain experiments which support the model showed that higher Riboflavin concentrations (> 0.125%) do not result in a further increase in stability of the corneal tissue. This is caused by the inhomogeneous distribution of induced crosslinks throughout the cornea due to the uneven absorption of the UV-light. The new model offers the possibility to optimize the treatment individually for every patient depending on their corneal thickness in terms of efficiency, saftey and treatment time.

Paper Details

Date Published: 11 February 2011
PDF: 11 pages
Proc. SPIE 7885, Ophthalmic Technologies XXI, 78850M (11 February 2011); doi: 10.1117/12.876797
Show Author Affiliations
S. Schumacher, IROC AG (Switzerland)
J. Wernli, IROC AG (Switzerland)
S. Scherrer, IROC AG (Switzerland)
M. Bueehler, IROC AG (Switzerland)
T. Seiler, IROC AG (Switzerland)
M. Mrochen, IROC AG (Switzerland)


Published in SPIE Proceedings Vol. 7885:
Ophthalmic Technologies XXI
Fabrice Manns; Per G. Söderberg; Arthur Ho, Editor(s)

© SPIE. Terms of Use
Back to Top